Innovent/Lilly’s Sintilimab, Developed In China, May Be Headed For Troubled US Waters

 
• By Sue Sutter
  
Bridge over water
Multiregional trials will be the true 'bridge' for global drug development and regulatory harmonization, FDA oncology leaders say. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers